Daily multidisciplinary rounds to implement the ventilator bundle decreases ventilator-associated pneumonia in trauma

Melvin E Stone1, David Snetman, Andrea O' Neill

  • 1Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, New York 10461, USA. Melvin.Stone@NBHN.net

Surgical Infections
|September 22, 2011
PubMed

Insights

Daily goal rounds (GR) using the ventilator bundle (VAPB) checklist significantly reduced ventilator-associated pneumonia (VAP) in trauma patients. While VAP incidence decreased, mortality rates remained similar, suggesting VAP impacts length of stay but not survival in this cohort.

Area of Science:

  • Critical Care Medicine
  • Infectious Disease Prevention
  • Trauma Patient Management

Background:

  • Ventilator-associated pneumonia (VAP) remains a challenge in trauma patients, despite the implementation of the ventilator bundle (VAPB).
  • High VAP rates persisted even after adopting the VAPB protocol.
  • A multidisciplinary team approach was introduced to improve VAPB adherence.

Purpose of the Study:

  • To evaluate the effectiveness of daily goal rounds (GR) focused on the VAPB in reducing VAP incidence in intubated trauma patients.
  • To assess the impact of GR on VAP rates and patient outcomes.

Main Methods:

  • A comparative study design was used, comparing a 10-month pre-GR period with a 10-month period of daily GR.
  • VAP incidence was prospectively tracked using National Nosocomial Infection Surveillance criteria.
  • Patient characteristics and outcomes were collected from trauma registry and medical records; patient groups were similar.

Main Results:

  • VAP incidence decreased by 67% in the GR group compared to the pre-GR group (p=0.02).
  • All-cause mortality rates were similar between the groups (16.5% vs. 21.3%; p=0.41).
  • Patients with VAP experienced significantly longer mean ventilator, SICU, and hospital days (p=0.01 for all).

Conclusions:

  • Daily multidisciplinary GRs focused on VAPB are effective in significantly decreasing VAP incidence in trauma patients.
  • VAP is associated with increased length of mechanical ventilation, SICU stay, and hospital stay.
  • The study lacked statistical power to determine the impact of GR or VAP on mortality due to a small number of deaths in the VAP cohort.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...